Search research articles
Contact Us
Filters
Showing results (1691-1700 of 1,873) with videos related to
Page
of 188
Sort By:
Journal of the American College of Cardiology
|
January 15, 2025
Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF
Shingo Matsumoto, Pardeep S Jhund, Alasdair D Henderson, et al.
JAMA Cardiology
|
November 17, 2024
Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial
Misato Chimura, Xiaowen Wang, Pardeep S Jhund, et al.
Journal of the American College of Cardiology
|
August 23, 2023
Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure
Toru Kondo, Xiaowen Wang, Mingming Yang, et al.
European Heart Journal
|
September 11, 2019
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske, Carsten Tschöpe, Rudolf A de Boer, et al.
Circulation
|
November 2, 2022
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Roxana Mehran, Philippe Gabriel Steg, Marc A Pfeffer, et al.
JACC. Heart Failure
|
December 1, 2022
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel
Mitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
Journal of the American College of Cardiology
|
December 16, 2022
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction
Mikhail N Kosiborod, Ankeet S Bhatt, Brian L Claggett, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 8, 2019
Chemical disarming of isoniazid resistance in <i>Mycobacterium tuberculosis</i>
Kelly Flentie, Gregory A Harrison, Hasan Tükenmez, et al.
Circulation. Heart Failure
|
February 22, 2023
A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study
Niklas Dyrby Johansen, Muthiah Vaduganathan, Deewa Zahir, et al.
European Journal of Heart Failure
|
August 31, 2024
Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction
Shingo Matsumoto, Alasdair D Henderson, Li Shen, et al.
Page
of 188
Search research articles
Search
Showing results (1691-1700 of 1,873) with videos related to
Sort By:
Page
of 188
Journal of the American College of Cardiology
|
January 15, 2025
Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF
Shingo Matsumoto, Pardeep S Jhund, Alasdair D Henderson, et al.
JAMA Cardiology
|
November 17, 2024
Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial
Misato Chimura, Xiaowen Wang, Pardeep S Jhund, et al.
Journal of the American College of Cardiology
|
August 23, 2023
Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure
Toru Kondo, Xiaowen Wang, Mingming Yang, et al.
European Heart Journal
|
September 11, 2019
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske, Carsten Tschöpe, Rudolf A de Boer, et al.
Circulation
|
November 2, 2022
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Roxana Mehran, Philippe Gabriel Steg, Marc A Pfeffer, et al.
JACC. Heart Failure
|
December 1, 2022
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel
Mitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
Journal of the American College of Cardiology
|
December 16, 2022
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction
Mikhail N Kosiborod, Ankeet S Bhatt, Brian L Claggett, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 8, 2019
Chemical disarming of isoniazid resistance in <i>Mycobacterium tuberculosis</i>
Kelly Flentie, Gregory A Harrison, Hasan Tükenmez, et al.
Circulation. Heart Failure
|
February 22, 2023
A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study
Niklas Dyrby Johansen, Muthiah Vaduganathan, Deewa Zahir, et al.
European Journal of Heart Failure
|
August 31, 2024
Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction
Shingo Matsumoto, Alasdair D Henderson, Li Shen, et al.
Page
of 188